Clinical Trial Update: Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer

View source ↗

Summary

This clinical trial update reports on genetic determinants of response to neoadjuvant cisplatin-based chemotherapy in urothelial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: University of Chicago | Conditions: Urothelial Cancer | Status: COMPLETED